Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer

por Lasalvia-Prisco, Eduardo, Garcia-Giralt, Emilio, Vázquez, Jesús, Aghazarian, Marta, Lasalvia-Galante, Eduardo, Larrañaga, Joshemaria, Spera, Gonzalo
Publicado 2008

Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

por Hurvitz, Sara A., Martin, Miguel, Jung, Kyung Hae, Huang, Chiun-Sheng, Harbeck, Nadia, Valero, Vicente, Stroyakovskiy, Daniil, Wildiers, Hans, Campone, Mario, Boileau, Jean-François, Fasching, Peter A., Afenjar, Karen, Spera, Gonzalo, Lopez-Valverde, Vanesa, Song, Chunyan, Trask, Peter, Boulet, Thomas, Sparano, Joseph A., Symmans, W. Fraser, Thompson, Alastair M., Slamon, Dennis
Publicado 2019